Review Unravels Bidirectional Mitophagy-Pyroptosis Axis as Key Regulator of Cell Fate and Inflammation
Background
Cellular inflammation and programmed cell death are critical in disease progression, yet their intricate regulatory mechanisms remain a focus of research. Pyroptosis, a highly inflammatory form of programmed cell death, is often triggered by NLRP3 inflammasome activation. Simultaneously, mitophagy, the selective degradation of damaged mitochondria, is crucial for maintaining cellular homeostasis and preventing inflammation. A deeper understanding of how these two fundamental processes interact is vital for developing novel therapeutic strategies for widespread conditions like neurodegeneration and metabolic inflammation.
Study Design
This comprehensive review synthesized current scientific literature to unravel the intricate, bidirectional relationship between mitophagy and pyroptosis. The authors systematically analyzed molecular mechanisms, key signaling pathways, and the pathological implications of this axis across various organ injuries and diseases. The review aimed to identify how these processes regulate cell fate and inflammation, highlighting potential therapeutic opportunities by targeting their interplay. It examined existing evidence on how mitophagy influences pyroptosis and vice-versa, and explored the roles of specific molecular modules in modulating this axis.
Results
The review established that mitophagy and pyroptosis form a complex, bidirectional regulatory network. Mitophagy actively suppresses NLRP3 inflammasome activation by efficiently removing damaged mitochondria, thereby reducing the release of pro-inflammatory mtROS and mtDNA, which in turn blocks pyroptosis. Conversely, pyroptosis can inhibit mitophagy through the release of inflammatory mediators and the activation of caspase-1, creating dynamic feedback loops. Key signaling modules such as PINK1/Parkin, NOD2-RIPK2, Nrf2/HO-1, and AMPK were identified as critical modulators of both mitophagy and pyroptosis. > These interactive processes are broadly implicated in determining inflammation intensity and cell survival across various organ injuries, including those affecting the brain, liver, kidney, lung, bone, and heart.
Key Findings
- Mitophagy suppresses
NLRP3 inflammasomeactivation by clearing damaged mitochondria, reducingmtROSandmtDNArelease, thereby blocking pyroptosis. - Pyroptosis can inhibit mitophagy via inflammatory mediators and
caspase-1activation, forming a bidirectional feedback loop. - Signaling modules like
PINK1/Parkin,NOD2-RIPK2,Nrf2/HO-1, andAMPKcritically modulate both mitophagy and pyroptosis. - The mitophagy-pyroptosis axis is broadly implicated in organ injuries (brain, liver, kidney, lung, bone, heart) and diseases like neurodegeneration and metabolic inflammation.
- Targeting this axis with natural small molecules or traditional Chinese medicine represents a promising strategy for precision therapy.
Why It Matters
Understanding the mitophagy-pyroptosis axis offers a transformative paradigm for precision therapy, moving beyond single-target interventions. This review highlights that modulating this intricate network, potentially with natural small molecules or traditional Chinese medicine, could address complex pathological states like neurodegeneration, metabolic inflammation, and immune evasion. It suggests that future therapeutic strategies should consider the dynamic, bidirectional nature of these processes, aiming for a balanced modulation rather than isolated activation or inhibition. This integrated approach could lead to more effective and targeted interventions for diseases where both inflammation and cell death are central drivers of pathology.
mitophagy
pyroptosis
inflammation
cell death
neurodegeneration
metabolic inflammation